Is Vision Training Working? How Progress Is Tracked

Updated 2026-10-23

Written by the Optics Trainer team from published research, with every source linked below. Not yet reviewed by a clinician.

Is vision therapy working? It is a fair question a few weeks into any program, and it is hard to answer by feel alone. Symptoms can ease for reasons that have nothing to do with the exercises, and real changes in how the eyes work can be invisible day to day. This guide explains how eye care professionals track vision therapy progress, how long programs ran in the main trials, why symptoms and measurements sometimes disagree, what happens after treatment stops, and when it makes sense to ask for a change of plan. It does not promise that any program will work for you.

Is vision therapy working? Start with what is being measured

Progress means different things for different conditions. For convergence insufficiency (CI), where the eyes struggle to turn in together up close, clinicians look at symptoms and at measured eye-teaming skills. For lazy eye (amblyopia), the main measure is how many lines the weaker eye can read on an eye chart. Our guide to whether vision therapy works covers what trials found for each condition.

Two kinds of evidence matter: For clinicians who want to measure eye movements objectively, Optics Tracker is our clinical eye-tracking platform.

Symptoms: what you or your child notice, such as eye strain, headaches, double vision or losing your place. In CI trials, these are scored with a questionnaire.
Signs: things a clinician measures in the office, such as how close the eyes can converge, how strong the eye-teaming range is, or eye chart acuity.

How long does vision therapy take? What the trials used

There is no single answer, and no trial can tell you how long your own program will take. What the studies can show is how long their programs ran and when they checked results.

Program length and check-ins in key trials
Study	Who	Program	When progress was checked
CITT (2008)	Children 9 to 17 with CI	12 weeks	After 4 and 8 weeks, and at the end
CITT-ART (2019)	Children 9 to 14 with CI	16 weeks of office therapy or placebo	At 16 weeks
CONCUSS (2026)	Ages 11 to 25 with CI after concussion	Twice weekly, 16 sessions in all	After 6 weeks and after 16 sessions
PEDIG patching (2003)	Children under 7 with moderate amblyopia	2 or 6 hours of daily patching	At 4 months
PEDIG glasses alone (2006)	Children 3 to under 7 with untreated anisometropic amblyopia	New glasses only	Every 5 weeks until vision stopped improving
PEDIG iPad game (2016)	Children 5 to 12 with amblyopia	16 weeks	At 4, 8, 12 and 16 weeks

How clinicians track progress in convergence insufficiency

In the CITT trials, progress was judged on three things together:

Symptoms, using the Convergence Insufficiency Symptom Survey (CISS). It has 15 questions and a score from 0 to 60, where higher means more symptoms. In CITT, a score under 16 counted as no longer symptomatic, and a drop of 10 points or more counted as improved.
Near point of convergence (NPC): how close a target can come to the nose before it doubles or one eye drifts out. Under 6 cm was normal in CITT.
Positive fusional vergence (PFV): how much the eyes can turn in to keep an image single as prisms make it harder. CITT used a value above 15 prism diopters, plus a standard comparison rule called Sheard's criterion, as normal.

Why symptoms and measurements can disagree

Feeling better is the goal, but it is not proof that the exercises did the work. In the CITT trial, children in the placebo office therapy group also reported fewer symptoms: their average CISS score fell 7.8 points over 12 weeks.

In the CITT-ART trial, office therapy improved the measured signs more than placebo did: the near point of convergence improved 10.4 cm with therapy and 6.2 cm with placebo, and eye-teaming range rose 23.2 prism diopters with therapy and 8.8 with placebo. But symptom scores improved almost as much in both groups, 11.8 points with therapy and 10.4 with placebo, and that difference was not statistically significant. The researchers suggested that wanting to please the study team, a placebo effect, or shared parts of the two programs could explain it, and wrote that "it may not be prudent to use the CISS alone" to judge success.

You can ask your clinician to re-measure the signs, as well as ask how you feel.

Tracking amblyopia, and what happens after treatment stops

For lazy eye, the American Academy of Ophthalmology's 2023 Amblyopia Preferred Practice Pattern says the first follow-up visit is usually 2 to 3 months after treatment starts, depending on the treatment and the child's age. Measuring vision in the weaker eye is the main goal of that visit. The clinician also asks how well the plan is being followed, checks for side effects and makes sure the stronger eye is still doing well.

Progress can take time. In a 2006 PEDIG study of glasses alone in children with untreated anisometropic amblyopia (a large difference in prescription between the eyes), vision improved by 2 or more lines in 77% of children, and improvement took up to 30 weeks to level off. In the 2003 PEDIG patching trial, where patching was combined with at least 1 hour a day of close-up activities, vision improved an average of 2.4 lines after 4 months with either 2 or 6 hours of daily patching.

Gains can also slip. A 2004 PEDIG study followed 145 children after successful treatment ended and found amblyopia came back in 24% within a year. Among children who had been patching 6 to 8 hours a day, it came back more often when patching stopped suddenly than when it was cut to 2 hours a day first, though that study was observational. When and how to reduce treatment is your clinician's decision. A later PEDIG analysis concluded that all children treated for amblyopia need careful, long-term follow-up.

For CI, the CITT follow-up looked at whether symptom relief lasted. In the CITT follow-up, 84.4% of children who were symptom-free after office therapy were still symptom-free a year later. The home and placebo groups in that follow-up were small, though the authors said their data suggest a similar outcome for children who were symptom-free after the home programs.

When to ask about changing the plan

The amblyopia guideline gives a concrete example. If vision has not improved after about 3 months, and testing is reliable and the treatment is being done, the clinician may keep or increase the treatment or try another option. If vision still does not improve despite good adherence, it says to consider whether something else is causing the reduced vision, and if vision gets worse, to retest it, recheck the glasses prescription and confirm the treatment is being done.

For adults, there is no standard timeline. A 2020 Cochrane review found only six adult trials of CI treatment, with just one at low risk of bias, and called the adult evidence less clear than the evidence for children.

Questions worth bringing to a follow-up visit:

Which measurements have changed since we started, and by how much?
Is the amount of practice we are actually doing enough for this plan?
When will we decide whether to continue, change or stop?
If we stop, how will we check that the gains hold?
What should make us call before the next visit, such as new double vision or headaches?

Where Optics Trainer fits

One point to keep clear: a score, level or streak in a training app is not a clinical measure. In the 2016 PEDIG trial of a binocular iPad game, the game's log files showed how much children played, and only 22.2% of the children with log data did more than three-quarters of their assigned play. But whether vision improved was judged with an eye chart in the clinic. Your clinician's measurements are what tell you whether a program is working.

Optics Trainer is a set of game-based vision and brain training apps for iPhone, iPad, Android, web browsers and Meta Quest. Its games practice eye teaming with convergence and divergence levels, depth and visual reaction, and some give each eye its own target while both eyes stay open. It does not measure or track clinical progress, it is not a treatment or diagnosis, it is not FDA cleared, and it was not tested in the studies described above. For practicing safely at home as part of a clinician's plan, see our guide to home vision therapy.

Optics Trainer is not a substitute for professional diagnosis or prescribed care. Consult your eye care professional for guidance about your specific condition. If your clinician agrees that home practice fits your plan, mobile and web access is $14.99 a month or $149.99 a year. The phone and tablet apps start with a 7-day free trial, and a free web account includes 3 plays a day. VR access is $19.99 a month or $199 a year after a 7-day free trial.

Frequently asked questions

How do I know if vision therapy is working?

Ask your clinician to re-measure the signs that led to the diagnosis, such as near point of convergence and eye-teaming range for convergence insufficiency, or eye chart vision for lazy eye. Feeling better matters too, but in convergence insufficiency trials, symptoms also improved with placebo.

How long does vision therapy take to work?

It depends on the condition and the person. In the main convergence insufficiency trials, programs ran 12 weeks (CITT) and 16 weeks (CITT-ART). In lazy eye trials, results were checked at about 4 months, and with glasses alone improvement took up to 30 weeks to level off.

How long does vision therapy take for adults?

There is no standard answer. Most trial participants were children, and a 2020 Cochrane review found the adult evidence less clear. The CONCUSS trial, which included people up to age 25 with convergence insufficiency after a concussion, used 16 twice-weekly office sessions.

How long does vision therapy take for kids?

In the CITT trials for convergence insufficiency, children had 12 to 16 weeks of therapy. For lazy eye, the AAO guideline suggests a first follow-up 2 to 3 months after treatment starts, and later visits decide whether to continue, change or taper treatment.

Can vision therapy results go away?

They can. For lazy eye, about a quarter of successfully treated children had it come back within a year of stopping treatment in a PEDIG study, so follow-up visits matter. For convergence insufficiency, 84.4% of children who were symptom-free after office therapy in the CITT follow-up were still symptom-free a year later.

What if vision therapy is not working?

Raise it at your next visit. Your clinician can check whether the practice is being done as planned, recheck glasses, re-measure your eyes, change the treatment or look for another cause. For lazy eye, the AAO guideline suggests reviewing the plan if vision has not improved after about 3 months.

Does a higher score in a vision game mean my eyes are improving?

Not on its own. A game score shows how you did in the game, not how your eyes work. Whether your vision or eye teaming has changed is something your eye care professional measures in the office.